Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer

BACKGROUND: Breast cancer mainly occurs in young and premenopausal women; its incidence is increasing annually. Patients with triple-negative breast cancer (TNBC) have relatively high recurrence and transfer rates during the operation and 3 years after postoperative adjuvant chemotherapy. Currently,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Feng, Chen, Ru-Yue, Hou, Jun, Guo, Jing, Dong, Tian-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100709/
https://www.ncbi.nlm.nih.gov/pubmed/35647172
http://dx.doi.org/10.12998/wjcc.v10.i12.3698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100709/
https://www.ncbi.nlm.nih.gov/pubmed/35647172
http://dx.doi.org/10.12998/wjcc.v10.i12.3698

Ejemplares similares